Biocon Limited

BIOCON.BO·BSE·Healthcare
Compare
361.40+17.40 (+5.06%)today
At close: Nov 5, 3:51 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close344.00
Open351.00
Day range349.25364.25
52-week range318.50447.00
Off day high−0.78%
Off 52-week high−19.15%
Volume525.27K
Avg. volume (3M)439.62K
Market cap591.88B
EPS (TTM)2.98
Forward P/E33.22
P/E ratio (TTM)121.28
Dividend yield0.15% (0.5000)
Beta (5Y)0.34
Shares outstanding1.64B
Short interest—
Earnings dateNov 4, 2026 (est.)
Analyst target440.16
Profit margin2.86%

Against its peers

Compare in full ›
BIOCON.BO 1548.HK 005250.KS ANTHEM.NS 085660.KQ 3759.HK
Market cap 591.88B 76.81B 438.13B 514.81B 677.77B 55.85B
P/E (TTM) 121.3 — — 84.4 — 27.4
Forward P/E 33.2 85.8 — 60.4 — 17.2
Price/book 1.7 2.4 — 15.7 — 2.8
Dividend yield 0.15% — 3.14% 0.23% — 0.78%
1-year change −10.65% +109.10% −39.90% +27.52% −45.74% +19.72%
Today +5.06% −0.94% +1.47% +2.84% +5.96% +3.47%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Express Pharma·Positive

Biocon secures Yesintek biosimilar rights in nine markets

Biocon has signed a licence agreement with Janssen Sciences Ireland to enable the commercialisation of Yesintek, its proposed biosimilar to Stelara (ustekinumab), in Australia, Brazil, China, Hong Kong, Israel, Mexico, New Zealand, South…

From the 4Search news index, newest first.

In the news

44mentions in 30 days
44with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 44 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance